Managers / Q1 2024 · view latest →
Clayton, Dubilier & Rice, LLC
CIK 0001538642 · 550 MADISON AVENUE, 32ND FLOOR, NEW YORK, NY, 10022 · 212-407-5200
Reported Value
$619M
Q1 2024
Positions
4
Filings on Record
31
2019–present window
Filed
Apr 26, 2024
original filing
Summary
Clayton, Dubilier & Rice, Llc reported $619M in U.S.-listed holdings across 4 positions for Q1 2024.
The portfolio is heavily concentrated: Agilon Health alone accounts for 98.6% of reported value.
Compared with Q4 2023, the fund opened 0 new positions and exited 1.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Other · 98.6% · $610M
- Common Stock · 1.4% · $9M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $536M | 2 | May 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $595M | 2 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $677M | 2 | Nov 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $357M | 2 | Jul 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $436M | 2 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $193M | 3 | Feb 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $402M | 4 | Nov 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $662M | 4 | Aug 1, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $619M | 4 | Apr 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $3.7B | 5 | Feb 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $5.4B | 5 | Nov 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $6.8B | 7 | Aug 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $9.2B | 7 | May 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $7.04T | 7 | Jan 30, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $9.7B | 8 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $11.3B | 9 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $12.3B | 9 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $14.0B | 9 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $12.7B | 10 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $12.0B | 9 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.7B | 8 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.2B | 8 | Feb 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.9B | 9 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.2B | 9 | Aug 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $731M | 9 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.4B | 9 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.4B | 9 | Nov 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $670M | 8 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.